Viewing StudyNCT00100672



Ignite Creation Date: 2024-05-05 @ 11:41 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00100672
Status: COMPLETED
Last Update Posted: 2011-07-04
First Post: 2005-01-04

Brief Title: Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Cancer
Sponsor: INSYS Therapeutics Inc
Organization: INSYS Therapeutics Inc

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-12
Start Date Type: None
Primary Completion Date: 2009-10
Primary Completion Date Type: ACTUAL
Completion Date: 2010-11
Completion Date Type: ACTUAL
First Submit Date: 2005-01-04
First Submit QC Date: January 4 2005
Study First Post Date: 2005-01-05
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2011-06-30
Last Update Post Date: 2011-07-04
Last Update Post Date Type: ESTIMATED